EUVIMEDEUVIMED entdecken
EditorialLeitlinieOpen Access · CC BY 4.0

Imlifidase for Kidney Transplantation of Highly Sensitized Patients With a Positive Crossmatch: The French Consensus Guidelines

Lionel Couzi, Paolo Malvezzi, Lucile Amrouche, Dany Anglicheau, Gilles Blancho, Sophie Caillard, Marine Freist, Gwenda Line Guidicelli, Nassim Kamar, Carmen Lefaucheur, Christophe Mariat, Alice Koenig und 5 weitere

Transplant International · 2023

DOI: 10.3389/ti.2023.11244 ↗

Kurz gefasst

Editorial in der Zeitschrift Transplant International, 2023. Verfasst von Lionel Couzi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France. Hauptthemen laut MEDLINE: Kidney Transplantation. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Imlifidase recently received early access authorization for highly sensitized adult kidney transplant candidates with a positive crossmatch against an ABO-compatible deceased donor. These French consensus guidelines have been generated by an expert working group, in order to homogenize patient selection, associated treatments and follow-up. This initiative is part of an international effort to analyze properly the benefits and tolerance of this new costly treatment in real-life. Eligible patients must meet the following screening criteria: cPRA ≥ 98%, ≤ 65-year of age, ≥ 3 years on the waiting list, and a low risk of biopsy-related complications. The final decision to use Imlifidase will be based on the two following criteria. First, the results of a virtual crossmatch on recent serum, which shall show a MFI for the immunodominant donor-specific antibodies (DSA) > 6,000 but the value of which does not exceed 5,000 after 1:10 dilution. Second, the post-Imlifidase complement-dependent cytotoxicity crossmatch must be negative. Patients treated with Imlifidase will receive an immunosuppressive regimen based on steroids, rATG, high dose IVIg, rituximab, tacrolimus and mycophenolic acid. Frequent post-transplant testing for DSA and systematic surveillance kidney biopsies are highly recommended to monitor post-transplant DSA rebound and subclinical rejection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationAdultHumansChild, PreschoolHistocompatibility TestingHLA AntigensGraft RejectionImmunosuppressive AgentsAntibodiesIsoantibodies

Stichwörter der Autor:innen

desensitizationhighly sensitized patientsimlifidasekidney transplantationpositive crossmatch

Substanzen

HLA AntigensImmunosuppressive AgentsAntibodiesIsoantibodies

Autor:innen und Institutionen

  • Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
  • CNRS-UMR 5164 Immuno ConcEpT, Université de Bordeaux, Bordeaux, France.
  • Centre Hospitalier Universitaire de Grenoble, La Tronche, France.
  • Hôpital Necker-Enfants Malades, Paris, France.
  • Centre Hospitalier Universitaire (CHU) de Nantes, Nantes, France.
  • Hôpital Civil, Strasbourg, Strasbourg, France.

Zitieren

APA

Couzi, L., Malvezzi, P., Amrouche, L., Anglicheau, D., Blancho, G., Caillard, S., Freist, M., Guidicelli, G. L., Kamar, N., Lefaucheur, C., Mariat, C., Koenig, A., Noble, J., Thaunat, O., Thierry, A., Taupin, J. L., & Bertrand, D. (2023). Imlifidase for Kidney Transplantation of Highly Sensitized Patients With a Positive Crossmatch: The French Consensus Guidelines. Transplant International. https://doi.org/10.3389/ti.2023.11244

Vancouver

Couzi L, Malvezzi P, Amrouche L, Anglicheau D, Blancho G, Caillard S, et al. Imlifidase for Kidney Transplantation of Highly Sensitized Patients With a Positive Crossmatch: The French Consensus Guidelines. Transplant International. 2023. doi:10.3389/ti.2023.11244

BibTeX
@article{Couzi2023,
  author = {Couzi, Lionel and Malvezzi, Paolo and Amrouche, Lucile and Anglicheau, Dany and Blancho, Gilles and Caillard, Sophie and Freist, Marine and Guidicelli, Gwenda Line and Kamar, Nassim and Lefaucheur, Carmen and Mariat, Christophe and Koenig, Alice and Noble, Johan and Thaunat, Olivier and Thierry, Antoine and Taupin, Jean-Luc and Bertrand, Dominique},
  title = {Imlifidase for Kidney Transplantation of Highly Sensitized Patients With a Positive Crossmatch: The French Consensus Guidelines},
  journal = {Transplant International},
  year = {2023},
  doi = {10.3389/ti.2023.11244}
}
Kostenlos starten →